ELECTROPORATION AND COMMERCIAL LIPOSOMES EFFICIENTLY DELIVER SOLUBLE-PROTEIN INTO THE MHC CLASS-I PRESENTATION PATHWAY - PRIMING INVITRO AND INVIVO FOR CLASS I-RESTRICTED RECOGNITION OF SOLUBLE-ANTIGEN

被引:43
作者
CHEN, WS
CARBONE, FR
MCCLUSKEY, J
机构
[1] FLINDERS UNIV S AUSTRALIA,MED CTR,DEPT CLIN IMMUNOL,BEDFORD PK,SA 5042,AUSTRALIA
[2] AUSTRALIAN RED CROSS SOC,DIV SA,BLOOD TRANSFUS SERV,ADELAIDE,SA 5000,AUSTRALIA
[3] MONASH UNIV,SCH MED,DEPT PATHOL & IMMUNOL,PRAHRAN,VIC 3181,AUSTRALIA
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
CYTOTOXIC T-LYMPHOCYTE; ANTIGEN PRESENTATION; COMMERCIAL LIPOSOME; ELECTROPORATION;
D O I
10.1016/0022-1759(93)90007-T
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Class I major histocompatibility complex (MHC)-restricted cytotoxic T lymphocyte responses to ovalbumin (OVA) were evaluated following delivery of soluble antigen mixed with commercial liposomes or by electroporation of soluble protein into target cells. Splenic antigen presenting cells (APC) and transfected L cell lines were sensitised for recognition by OVA-specific, class I-restricted T hybridomas when antigen was introduced by either method into live cells. Delivery of soluble OVA by both electroporation and commercial liposomes proved more efficient than osmotic loading in sensitising for class I presentation. OVA-specific cytotoxic T lymphocytes (CTL) were effectively primed in naive mice following reinjection of spleen cells pulsed with soluble OVA encapsulated by liposomes or electroporated in vitro. These CTL recognised the well defined OVA257-264 determinant in association with H-2K(b) and were derived under conditions where CTL activity obtained from cross priming by soluble OVA alone was undetectable. In addition, using electroporation and commercial liposomes, the loading of APC for OVA recognition required intact MHC-linked antigen presentation genes deleted in the T2-K(b) cell line. Antigen delivery to APC by electroporation and commercial liposomes provides a simple and efficient way of studying class I-restricted T cell recognition of soluble protein antigens.
引用
收藏
页码:49 / 57
页数:9
相关论文
共 35 条
[21]   PRESENTATION OF EXOGENOUS ANTIGEN WITH CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES [J].
ROCK, KL ;
GAMBLE, S ;
ROTHSTEIN, L .
SCIENCE, 1990, 249 (4971) :918-921
[22]   FINE SPECIFICITY OF CYTOTOXIC LYMPHOCYTES-T PRIMED INVIVO EITHER WITH VIRUS OR SYNTHETIC LIPOPEPTIDE VACCINE OR PRIMED INVITRO WITH PEPTIDE [J].
SCHILD, H ;
NORDA, M ;
DERES, K ;
FALK, K ;
ROTZSCHKE, O ;
WIESMULLER, KH ;
JUNG, G ;
RAMMENSEE, HG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1665-1668
[23]   IDENTIFICATION OF THE CLONED GENE FOR THE MURINE TRANSPLANTATION ANTIGEN H-2KB BY HYBRIDIZATION WITH SYNTHETIC OLIGONUCLEOTIDES [J].
SCHULZE, DH ;
PEASE, LR ;
OBATA, Y ;
NATHENSON, SG ;
REYES, AA ;
IKUTA, S ;
WALLACE, RB .
MOLECULAR AND CELLULAR BIOLOGY, 1983, 3 (04) :750-755
[24]   A GENE IN THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II REGION CONTROLLING THE CLASS-I ANTIGEN PRESENTATION PATHWAY [J].
SPIES, T ;
BRESNAHAN, M ;
BAHRAM, S ;
ARNOLD, D ;
BLANCK, G ;
MELLINS, E ;
PIOUS, D ;
DEMARS, R .
NATURE, 1990, 348 (6303) :744-747
[25]  
STAERZ UD, 1987, NATURE, V329, P447
[26]   INDUCTION OF CD8+ CYTOTOXIC T-CELLS BY IMMUNIZATION WITH PURIFIED HIV-1 ENVELOPE PROTEIN IN ISCOMS [J].
TAKAHASHI, H ;
TAKESHITA, T ;
MOREIN, B ;
PUTNEY, S ;
GERMAIN, RN ;
BERZOFSKY, JA .
NATURE, 1990, 344 (6269) :873-875
[27]   SUSCEPTIBILITY OF BETA-2-MICROGLOBULIN-DEFICIENT MICE TO TRYPANOSOMA-CRUZI INFECTION [J].
TARLETON, RL ;
KOLLER, BH ;
LATOUR, A ;
POSTAN, M .
NATURE, 1992, 356 (6367) :338-340
[28]   ASSEMBLY OF MHC CLASS-I MOLECULES ANALYZED INVITRO [J].
TOWNSEND, A ;
ELLIOTT, T ;
CERUNDOLO, V ;
FOSTER, L ;
BARBER, B ;
TSE, A .
CELL, 1990, 62 (02) :285-295
[29]   ASSOCIATION OF CLASS-I MAJOR HISTOCOMPATIBILITY HEAVY AND LIGHT-CHAINS INDUCED BY VIRAL PEPTIDES [J].
TOWNSEND, A ;
OHLEN, C ;
BASTIN, J ;
LJUNGGREN, HG ;
FOSTER, L ;
KARRE, K .
NATURE, 1989, 340 (6233) :443-448
[30]   ANTIGEN RECOGNITION BY CLASS-I RESTRICTED LYMPHOCYTE-T [J].
TOWNSEND, A ;
BODMER, H .
ANNUAL REVIEW OF IMMUNOLOGY, 1989, 7 :601-624